Pharmaceutical Technology

JULY 11, 2025

FDA Commissioner Marty Makary stated: “For far too long, drug developers have been playing a guessing game when navigating the FDA. Drug developers and capital markets alike want predictability. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Communication 52

Communication Packaging Hospitals Drug Development 52

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 59

Packaging Communication Hospitals Drug Pricing 59

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Diabetes 52

Diabetes Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Hospitals Communication Research Laboratories 52

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. Achieving good oral bioavailability for TPDs Rebecca Coutts is Senior Director of Pharmaceutical Development at PCI Pharma Services, a world leading CDMO providing integrated end-to-end drug development.

Packaging 52

Packaging Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 9, 2025

JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Documentation 52

Documentation Communication Packaging Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Labelling 52

Labelling Vaccines Insurance Coverage and Processing Packaging 52

Pharmaceutical Technology

JULY 3, 2025

“The integration of genomic data into routine care, combined with streamlined access to clinical trials via the NHS App, has the potential to accelerate drug development, reduce health inequalities, and unlock new models of preventative care.” How will RFK Jr’s American dream for vaccines play out?

Health and Personal Care Stores 52

Health and Personal Care Stores Hospitals Packaging Communication 52

Pharmaceutical Technology

JULY 15, 2025

The share price in the company had climbed 3.6% LaNova’s drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality. How will RFK Jr’s American dream for vaccines play out?

Packaging 75

Packaging Communication Hospitals Drug Development 75

Pharmaceutical Technology

JULY 16, 2025

Find out more Office of Management and Budget Director Russell Vought told reporters that the White House is on board with the substitute amendment to the rescissions package. How will RFK Jr’s American dream for vaccines play out? Data Insights The gold standard of business intelligence.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines Packaging Hospitals Communication 52

Pharmaceutical Technology

JULY 17, 2025

It is an advanced sterile fill-finish and packaging site supported by more than 200 employees. How will RFK Jr’s American dream for vaccines play out? Find out more The Ridgefield site will continue to produce a range of therapies for Sanofi while expanding its capacity to meet increasing demands from other pharmaceutical and biotech firms.

Packaging 52

Packaging Communication Hospitals Drug Development 52

Pharmaceutical Technology

JULY 18, 2025

Given the way the Hub is set up, it can closely engage with the rare disease community—biotechs, advocacy organisations, and more—without conflicts since it is not involved with the drug review process. Moreover, other threats to the early-stage drug development for rare diseases are also a concern.

Drug Development 52

Drug Development Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Packaging Hospitals 52

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Pricing 52

Pharmaceutical Technology

JUNE 6, 2025

wants to ensure the ensuing the US does not lag behind other countries in drug development. We want to make sure we are getting rid of the regulatory impediments [that stop drugs getting to market],” RFK Jr stated. Tasos Katopodis / Stringer via Getty Images. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 81

Insurance Coverage and Processing Communication Hospitals Drug Development 81

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Communication 52

Communication Packaging Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out?

Communication 52

Communication Customer Service Drug Pricing Packaging 52

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. Adding to these pressures is the surging demand for specialised capabilities as oncology drug development moves towards more complex therapies that require technical manufacturing expertise.

Communication 52

Communication Drug Pricing Packaging Hospitals 52

Pharmaceutical Technology

JUNE 27, 2025

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest does – is $1,350 in the US, whereas the same dose in the UK costs £175.80

Drug Pricing 59

Drug Pricing Compounding Packaging Communication 59

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 17, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Labelling Communication Packaging 52

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Labelling 84

Labelling Packaging Communication Hospitals 84

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging 64

Packaging Communication Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

STAT

OCTOBER 17, 2024

Eli Lilly, a chief Novo rival, uses Catalent for filling and packaging, and has complained openly about the deal. Continue to STAT+ to read the full story…

Diabetes 262

Diabetes Packaging Drug Pricing Drug Development 262

Safe Biologics

NOVEMBER 12, 2023

6 would prevent the HHS Secretary from requiring a switching study as part of the data package to receive the interchangeable designation. Pitts: The IRA makes the risks of developing new drugs too high On September 14th, an op-ed by former FDA Associate Commissioner Peter J. However, S.6 ASBM surveys of U.S.

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

Safe Biologics

DECEMBER 6, 2023

REMINDER: FDA Draft Guidance Would Remove Interchangeability Statement from Interchangeable Biosimilars Comments Due November 17th On September 15th, the Food and Drug Administration (FDA) released draft guidance removing the interchangeability statement from the product label/package insert. ASBM surveys of U.S. However, S.6

Biosimilars 130

Biosimilars Packaging Labelling Drug Development 130

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. pocket expenses account for only seven percent of the overall cost of developing drugs.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

BioPharma Dive

JUNE 23, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Diabetes 52

Diabetes Drug Pricing Packaging Drug Development 52

BioPharma Dive

JULY 14, 2025

XH4D via Getty Images A group of private equity firms are pouring funding into PCI Pharma Services, betting the contract drug development and manufacturing organization’s business is poised to grow in the years ahead. You can unsubscribe at anytime. and reportedly values PCI at $10 billion, according to The Wall Street Journal.

Drug Pricing 60

Drug Pricing Labelling Pharmaceutical Companies Pharmaceutical Companies 60

European Pharmaceutical Review

DECEMBER 26, 2023

Production cost is currently a fundamental concern for many gene therapy developers, particularly given that some treatments cost millions of dollars per single dose (eg, $3.5 million for Hemgenix [AAV5-hFIX-Padua]).

Drug Pricing 98

Drug Pricing Packaging Drug Development Vaccines 98

BioPharma Dive

JUNE 23, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales.

Vaccines 105

Vaccines Drug Pricing Immunity Immunization 105